Thermo Fisher CDR (Cad Hedged) (TMO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,325,000 | 7,540,000 | 5,818,000 | 2,981,000 | 2,399,000 |
| Receivables | 6,472,000 | 5,883,000 | 5,164,000 | 5,166,000 | 4,952,000 |
| Inventories | 4,029,000 | 3,829,000 | 3,648,000 | 3,454,000 | 3,370,000 |
| Other current assets | 1,131,000 | 982,000 | 1,145,000 | 1,137,000 | 1,172,000 |
| TOTAL | $21,957,000 | $18,234,000 | $15,775,000 | $12,738,000 | $11,893,000 |
| Non-Current Assets | |||||
| PPE Net | 5,912,000 | 5,180,000 | 4,887,000 | 4,736,000 | 4,749,000 |
| Intangibles | 38,726,000 | 38,652,000 | 38,870,000 | 39,157,000 | 39,728,000 |
| Other Non-Current Assets | 2,457,000 | 1,995,000 | 2,061,000 | 2,057,000 | 2,011,000 |
| TOTAL | $47,095,000 | $45,827,000 | $45,818,000 | $45,950,000 | $46,488,000 |
| Total Assets | $69,052,000 | $64,061,000 | $61,593,000 | $58,688,000 | $58,381,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,628,000 | 2,000 | 675,000 | 738,000 | 676,000 |
| Accounts payable and accrued liabilities | 2,175,000 | 1,703,000 | 1,385,000 | 1,599,000 | 1,920,000 |
| Accrued Expenses | 4,230,000 | 3,476,000 | 2,978,000 | 2,225,000 | 2,685,000 |
| TOTAL | $10,304,000 | $6,228,000 | $6,013,000 | $5,500,000 | $6,197,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,107,000 | 21,091,000 | 20,638,000 | 19,231,000 | 17,076,000 |
| Deferred Revenues | 1,271,000 | 1,047,000 | 975,000 | 938,000 | 916,000 |
| Other Non-Current Liabilities | 3,340,000 | 3,390,000 | 3,317,000 | 3,261,000 | 3,241,000 |
| TOTAL | $24,241,000 | $26,009,000 | $25,705,000 | $24,629,000 | $22,509,000 |
| Total Liabilities | $34,545,000 | $32,237,000 | $31,718,000 | $30,129,000 | $28,706,000 |
| Shareholders' Equity | |||||
| Common Shares | 437,000 | 437,000 | 436,000 | 435,000 | 434,000 |
| Retained earnings | 28,116,000 | 25,705,000 | 23,860,000 | 22,791,000 | 22,092,000 |
| Other shareholders' equity | -2,807,000 | -2,970,000 | -2,989,000 | -3,088,000 | -2,679,000 |
| TOTAL | $34,507,000 | $31,824,000 | $29,875,000 | $28,559,000 | $29,675,000 |
| Total Liabilities And Equity | $69,052,000 | $64,061,000 | $61,593,000 | $58,688,000 | $58,381,000 |